NCT03159507View on ClinicalTrials.gov

Effect of Omega-3 Index on Cellular Metabolism and Quality of Life

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

March 14, 2019

Study Completion Date

March 14, 2019

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

MAG-EPA

Based on the result of the participant's Omega-3 index obtained from the blood sampling of visit 1, the daily dose of MAG-EPA will be adjusted to obtain an Omega-3 Index of 8.

Trial Locations (1)

G5M 1J5

SCF Pharma, Rimouski

All Listed Sponsors
collaborator

Université du Québec à Rimouski

UNKNOWN

lead

SCF Pharma

INDUSTRY

NCT03159507 - Effect of Omega-3 Index on Cellular Metabolism and Quality of Life | Biotech Hunter | Biotech Hunter